NCPIC launched an online survey regarding the experiences of cannabis users who have visited a General Practitioner (GP) regarding any cannabis use concerns.
Treatment and Intervention
Governments, policy experts, researchers and randomly selected members of communities all support the idea of greater co-ordination of efforts aimed at reducing alcohol-related harm.
Suicide is a leading cause of death among people who misuse drugs and alcohol. The annual prevalence of attempted suicide among dependent drug users is equivalent to the lifetime prevalence in the general population.
Most individuals with cannabis use disorder do not seek treatment, and this is often due to problems with accessibility and concerns about privacy. Web-based therapy addresses these two major barriers to treatment uptake.
Over three million Australians have a lifetime alcohol use disorder and one in five will have co-occurring major depression in the last year.
The majority of buprenorphine-naloxone (Suboxone®) dosing in Australia involves supervised dosing of sublingual tablets in order to enhance medication adherence and to minimise aberrant behaviours such as diversion and/or injecting.
Although “evidence-based” policy is a goal for many, the realities of democratic politics dictate that most policy decisions also need to be acceptable to a majority of the voting population.
Despite its widespread use, relatively few cannabis users present to treatment, with only 31,980 episodes of care provided for primary cannabis use problems in 2006-07 (AIHW, 2008).